Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/20004Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Singhvi, Gautam | - |
| dc.contributor.author | Taliyan, Rajeev | - |
| dc.date.accessioned | 2025-11-10T10:54:35Z | - |
| dc.date.available | 2025-11-10T10:54:35Z | - |
| dc.date.issued | 2025-11 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1186/s43088-025-00706-x | - |
| dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/20004 | - |
| dc.description.abstract | Cancer is one of the leading causes of death globally, with the reported numbers rising every year. Although the medical fraternity has made considerable progress in early detection and treatment interventions, the numbers are expected to increase drastically by 2040. The most prevalent cause of mortality in people with diverse cancer types is likely multidrug resistance (MDR). As per recent reports, there have been increased incidences of cancer being reported globally, with projections of low-Human Development Index (HDI) countries being affected more in the near future. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Cancer mortality | en_US |
| dc.subject | Multidrug resistance (MDR) | en_US |
| dc.subject | Global cancer incidence | en_US |
| dc.subject | Low-HDI countries impact | en_US |
| dc.title | The role of diet and nutraceuticals in the amelioration of multidrug resistance amongst cancer patients | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Department of Pharmacy | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.